| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8531431 | International Immunopharmacology | 2018 | 8 Pages |
Abstract
This study highlights the protective effect of phloretin on CS-related airway mucus hypersecretion and inflammation, where EGFR, ERK and P38 might be involved. These findings suggest that phloretin could be a potential therapeutic drug for COPD.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Hao Wang, Ting Yang, Tao Wang, Nanya Hao, Yongchun Shen, Yanqiu Wu, Zhicheng Yuan, Lei Chen, Fuqiang Wen,